66
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Persons with Screening-detected Haemochromatosis: as Healthy as the General Population?

Pages 719-724 | Published online: 08 Jul 2009

  • Powell LW, Subramaniam VN, Yapp TR. Haemochromatosis in the new millennium. J Hepatol 2000;32:48-62.
  • Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol 1994;356:293-302.
  • Niederau C, Stremmel W, Strohmeyer GW. Clinical spectrum and management of haemochromalosis. Baillieres Clin Haematol 1994;7:881-901.
  • Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromalosis. Clin Chim Acta 1996;245:139-200.
  • Edwards CQ, Kushner JP. Screening for hemochromatosi s [see comments]. N Engl J Med 1993;328:1616-20.
  • Haddow JE, Ledue TB. Preventing manifestations of hereditary haemochromatosis through population based screening. J Med Screen 1994;1:16-21.
  • Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999;116:193-207.
  • Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosi s mutations [see comments]. J Med Genet 1997:34:275-8.
  • Åsberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannel ønning K, Fjøsne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
  • Adams PC. Population screening for haemochromatosis. Gut 2000;46:301-3.
  • Cogswell ME, Burke W, McDonnell SM, Franks AL. Screening for hemochromatosis. A public health perspective. Am J Prev Med 1999;16:134-40.
  • Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening. Ann Intern Med 1998;129:971-9.
  • Haddow JE, Bradley LA. Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled [Editorial]. Br Med J 1999;319:531-2.
  • Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associate d mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med 1998;129:946-53.
  • Bland M. An introduction to medical statistics. Oxford: Oxford University Press; 1995.
  • Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl 1979;634:1-70.
  • Edwards CQ, Griffen LM, Kushner JP. The morbidity of hemochromatosis among clinically unselected homozygotes: preliminary report. Adv Exp Med Biol 1994;356:303-8.
  • Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis : a changing scene. Am J Med 1991;90:445-9.
  • Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS. Genetic and phenotypic expression of hemochromatosis in Canadians. CIin Invest Med 1983;6:171-9.
  • Edwards CQ. Hemochromatosis. In: Lee GR, Paraskevas F, Foerster J, Greer JP, Lukem J, Rodgers GM, editors. Wintrobe's clinical hematology. Baltimore: Williams & Wilkins; 1999; p. 1056-70.
  • Roest M, van der Schouw YT, de VaIk B, Marx JJ, Tempelman MJ, de Groot PG, et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women [see comments]. Circulation 1999;100:1268-73.
  • Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland [see comments]. Circulation 1999;100:1274-9.
  • Deugnier Y, Turlin B, Loreal O. Iron and neoplasia. J Hepatol 1998;28 Suppl 1:21-5.
  • Bacon BR, Sadiq SA Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol 1997;92:784-9.
  • de VaIk B, Marx JJ. Iron, atherosclerosis, and ischemie heart disease [see comments]. Arch Intern Med 1999;159:1542-8.
  • Beutler E, Fditti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000; 133:329-37.
  • Hennekens CH, Buring JE. Descriptive studies. In: Mayrent SL, editor. Epidemiology in medicine. Boston: Little Brown; 1987. p. 101-31.
  • Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.